RotaShield®

On July 16, 1999, Wyeth-Lederle Vaccines temporarily suspended further distribution and administration of RotaShield® until more data on the potential association between vaccine administration and intussusception [a condition characterized by the folding of the intestine on itself] became available. The action was taken in consultation with the Food and Drug Administration following a recommendation from the Centers for Disease Control and Prevention to postpone administration because of reports to the Vaccine Adverse Events Reporting System (VAERS) of a possible association between the use of RotaShield® and the development of intussusception.

Source: fda.gov

If you or a loved one has been harmed by RotaShield®, you may want to contact a RotaShield® attorney for more information.